Survey on long-term use of avacopan for certain autoimmune diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This survey evaluates the safety and efficacy of avacopan, a medication used for treating microscopic polyangiitis and granulomatosis with polyangiitis, in Japanese patients over a long-term period. The study is observational, meaning it will collect data on patients currently receiving avacopan under real-world conditions rather than in a controlled experimental setting. By monitoring patient outcomes and side effects, the survey aims to provide insights into the drug's effectiveness and safety profile in everyday clinical practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan

Where it's running

• Research site
  Multiple Locations, Japan Recruiting

Study contacts

• Study coordinator: Kazunori Abe, director
• Email: rinsyousiken@pharm.kissei.co.jp
• Phone: 0356843575

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating skin lesions in patients with various types of vasculitis

  This study is testing how skin lesions from different types of vasculitis look under a microscope to help doctors better understand and treat these conditions.

  Recruiting at 4 sites University of Pennsylvania · Los Angeles, California and 9 other locations · NCT03004326

• Registry for women with vasculitis during pregnancy

  This study is gathering information from pregnant women with vasculitis to understand their experiences and health outcomes during and after pregnancy.

  Recruiting University of Pennsylvania · Tampa, Florida · NCT02593565

• Ocular Symptoms in ANCA-Associated Vasculitis

  This study tests ocular changes in adults with GPA, MPA, or related vasculitis to see how the eyes are involved.

  Recruiting Military Institute od Medicine National Research Institute · Warsaw · NCT07664709

• Low-dose steroid treatment with standard induction medicines for ANCA-associated vasculitis affecting the kidneys

  This trial will test whether giving only 4 weeks of steroids together with usual induction medicines (cyclophosphamide or rituximab) helps people with ANCA-associated vasculitis that has severely affected the kidneys while reducing steroid-related harms.

  Recruiting Phase 3 Ottawa Hospital Research Institute · Hamilton, Ontario and 1 other locations · NCT06983821

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

• Collection of tissue samples for vasculitis research

  This study is collecting tissue samples from patients with vasculitis to see if they can help researchers understand the disease better and find new ways to diagnose and treat it.

  Recruiting at 3 sites University of Pennsylvania · Boston, Massachusetts and 7 other locations · NCT02967068

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.